Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you about the changes in senior management personnel of the Company.
09-07-2024
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you about the change in senior management personnel of the Company.
02-07-2024

Alkem Laboratories Promoter Offloads Stake For Rs 177 Crore

Seema Singh offloaded 3.58 lakh shares at Rs 4,956 apiece, according to the block deal data on the NSE.
25-06-2024
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

In furtherance of the intimation captioned "US FDA Inspection at Company''s manufacturing facility located at Baddi, India" dated 27th March, 2024, this is to inform you that the US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility of the Company located at Baddi, India.
25-06-2024
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

This is to inform you that the trading window will remain closed from 29th June, 2024 until the expiry of 48hours after the date on which the Financial Results of the Company for quarter ended 30th June, 2024 are communicated to the Stock Exchanges.
24-06-2024
Bigul

How Alkem's 83-year-old founder is remaking India's 4th-largest pharma firm

Hailing from Okari, a remote village in Jehanabad district of Bihar, Singh and his brother, Samprada, moved to Mumbai in 1973 to start Alkem Laboratories with a seed capital of Rs 5 lakh
17-06-2024
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Resignation of Director

Dr. Dheeraj Sharma has tendered his resignation as an Independent Director of the Company vide email dated 14th June, 2024, due to pre-occupation. The requisite details as per SEBI (LODR) Regulations, 2015 are enclosed herewith.
14-06-2024
Bigul

Alkem Laboratories Ltd - 539523 - Request For Reclassification Received From Certain Members Of Promoter Group Of The Company

This is in furtherance to our earlier intimation dated 9th February, 2024 in relation to proposed reclassification of certain members of Promoter Group of the Company to ''Public'' category.
14-06-2024
Bigul

Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order

Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
10-06-2024
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisition

We wish to inform you that the Company has agreed to invest in (Pre-Series A) Compulsorily Convertible Preference Shares of M/s HaystackAnalytics Private Limited. The requisite details with respect to the same are enclosed herewith.
06-06-2024
Next Page
Close

Let's Open Free Demat Account